Final answer:
The FDA recommended in 2007 that pediatric cough and cold medications be relabeled as not suitable for children under the age of six due to lack of efficacy evidence and potential harm. Additional warnings were issued in 2015 about the risks of codeine-containing medications for children. It is important for parents and caregivers to consult healthcare professionals for safe treatments for young children.
Step-by-step explanation:
FDA Recommendations for Pediatric Cough and Cold Medications:
In 2007, the FDA recommended that all pediatric cough and cold medications be relabeled as not indicated for use in children under the age of six. This recommendation followed concerns over the lack of evidence on the efficacy of these medications in young children and the potential for harm including serious adverse effects such as accidental overdoses. Such concerns are in agreement with views from the Environmental Protection Agency (EPA) and Centers for Disease Control (CDC). Additionally, in 2015 the FDA issued a warning regarding the use of codeine-containing cough medications in children due to the risk of breathing problems. It is crucial for caregivers to be cautious when administering cough and cold medications to young children and to seek the guidance of healthcare professionals. Furthermore, labels on over-the-counter cold and cough remedies often include aspirin which is associated with Reye's Syndrome a rare but potentially fatal condition in children and teenagers recovering from viral infections.
Parents and caregivers should be aware of these guidelines and consider visiting a healthcare provider for safe and effective treatment alternatives particularly for children under six years of age. Measures such as getting recommended vaccinations, like the flu shot and being educated on the judicious use of antibiotics can also contribute to better health outcomes for children.